BRINP1 and attention deficit-hyperactivity disorder: Methylphenidate did not reduce the hyperactivity of Brinp1−/− mice, indicating that Brinp1 deletion is unlikely to directly affect the dopaminergic pathways of the prefrontal cortex, as hypothesised for ADHD aetiology [55].